The combination of Glimepiride 3 mg and Metformin Hydrochloride 500 mg PR (Prolonged Release) is an oral antidiabetic medication used for the management of Type 2 Diabetes Mellitus. This dual-drug therapy helps control blood sugar levels by improving insulin secretion and reducing glucose production in the liver. Glimepiride stimulates the pancreas to release more insulin. Metformin PR improves insulin sensitivity and reduces glucose absorption from the intestine. This combination is commonly prescribed when diet, exercise, or single-drug therapy does not adequately control blood glucose levels.
Uses :
This medicine is used for:
- Management of Type 2 diabetes mellitus
- Improving glycemic control in diabetic patients
- Reducing fasting and post-meal blood glucose levels
- Preventing long-term diabetic complications such as kidney, nerve, and eye damage.
Indications :
Doctors may prescribe this combination in the following conditions:
- Uncontrolled Type 2 diabetes
- Patients not responding adequately to Metformin alone
- Patients requiring combination oral antidiabetic therapy
- Insulin resistance with high blood sugar levels.
Common Side Effects :
Some patients may experience:
- Nausea
- Diarrhea
- Stomach discomfort
- Headache
- Dizziness
- Low blood sugar (hypoglycemia)
- Metallic taste in mouth
Serious Side Effects (Rare)
- Severe hypoglycemia
- Lactic acidosis (rare but serious condition related to Metformin)
- Allergic reactions
- Severe weakness or breathing difficulty
Seek medical help immediately if severe symptoms occur.
Storage Conditions :
- Store below 25°C
- Keep in a dry place
- Protect from moisture and sunlight
- Keep out of reach of children.
“To be used only with a valid prescription or as directed by the physician.”
